Numerous TMED proteins have been shown to be dysregulated in mild cognitive impairment (MCI) and AD brains: While TMED5 expression increases in the AD parietal cortex [105], expression of both TMED4 and TMED9 decreases in the AD frontal cortex [106–108]. Here, TMED9 is linked to Alzheimer disease.